In an in vivo model of stroke, pharmacological inhibition of PANX1 channels with the clinically used uricosuric drug probenecid decreased infarct size and reduced inflammatory cell recruitment (Freitas-Andrade, et al. 2017). This evidence concerns the gene PANX1 and Stroke.